Abstract:Background: Diabetes, a globally escalating health concern, necessitates innovative solutions for efficient detection and management. Blood glucose control is an essential aspect of managing diabetes and finding the most effective ways to control it. The latest findings suggest that a basal insulin administration rate and a single, high-concentration injection before a meal may not be sufficient to maintain healthy blood glucose levels. While the basal insulin rate treatment can stabilize blood glucose levels over the long term, it may not be enough to bring the levels below the post-meal limit after 60 min. The short-term impacts of meals can be greatly reduced by high-concentration injections, which can help stabilize blood glucose levels. Unfortunately, they cannot provide long-term stability to satisfy the post-meal or pre-meal restrictions. However, proportional-integral-derivative (PID) control with basal dose maintains the blood glucose levels within the range for a longer period. Aim: To develop a closed-loop electronic system to pump required insulin into the patient's body automatically in synchronization with glucose sensor readings. Methods: The proposed system integrates a glucose sensor, decision unit, and pumping module to specifically address the pumping of insulin and enhance system effectiveness. Serving as the intelligence hub, the decision unit analyzes data from the glucose sensor to determine the optimal insulin dosage, guided by a pre-existing glucose and insulin level table. The artificial intelligence detection block processes this information, providing decision instructions to the pumping module. Equipped with communication antennas, the glucose sensor and micropump operate in a feedback loop, creating a closed-loop system that eliminates the need for manual intervention. Results: The incorporation of a PID controller to assess and regulate blood glucose and insulin levels in individuals with diabetes introduces a sophisticated and dynamic element to diabetes management. The simulation not only allows visualization of how the body responds to different inputs but also offers a valuable tool for predicting and testing the effects of various interventions over time. The PID controller's role in adjusting insulin dosage based on the discrepancy between desired setpoints and actual measurements showcases a proactive strategy for maintaining blood glucose levels within a healthy range. This dynamic feedback loop not only delays the onset of steady-state conditions but also effectively counteracts post-meal spikes in blood glucose. Conclusion: The WiFi-controlled voltage controller and the PID controller simulation collectively underscore the ongoing efforts to enhance efficiency, safety, and personalized care within the realm of diabetes management. These technological advancements not only contribute to the optimization of insulin delivery systems but also have the potential to reshape our understanding of glucose and insulin dynamics, fostering a new era of precision medicine in the treatment of diabetes.

An Intelligent Wearable Artificial Pancreas Patch Based on a Microtube Glucose Sensor and an Ultrasonic Insulin Pump

A Microtube-Based Wearable Closed-Loop Minisystem for Diabetes Management.

Closed-Loop Diabetes Minipatch Based on a Biosensor and an Electroosmotic Pump on Hollow Biodegradable Microneedles

A wearable, minimally-invasive, fully electrochemically-controlled feedback minisystem for diabetes management.

A wearable, rapidly manufacturable, stability-enhancing microneedle patch for closed-loop diabetes management

An Integrated Intelligent Insulin Pump

Engineering Synthetic Artificial Pancreas Using Chitosan Hydrogels Integrated with Glucose-Responsive Microspheres for Insulin Delivery.

Integrated electronic/fluidic microneedle system for glucose sensing and insulin delivery

An Intelligent Nanoscale Insulin Delivery System

A Fully Integrated Closed‐Loop System Based on Mesoporous Microneedles‐Iontophoresis for Diabetes Treatment

Antidiabetic Close Loop Based on Wearable DNA-Hydrogel Glucometer and Implantable Optogenetic Cells

An injectable and retrievable bioartificial pancreas fabricated by time-sequentially assembling islets-laden microgels for minimally invasive treatment of type 1 diabetes

Microneedles Integrated with Pancreatic Cells and Synthetic Glucose‐Signal Amplifiers for Smart Insulin Delivery

A PZT Insulin Pump Integrated with a Silicon Micro Needle Array for Transdermal Drug Delivery

The Design of an Intelligent Insulin Pump

Wearable, Sensing-Controlled, Ultrasound-Based Microneedle Smart System for Diabetes Management

Technological Advances of Wearable Device for Continuous Monitoring of In Vivo Glucose

Masticatory System–inspired Microneedle Theranostic Platform for Intelligent and Precise Diabetic Management

Artificial intelligence powered glucose monitoring and controlling system: Pumping module

Design and Development of a Mechatronic System for Releasing and Recycling of Nanomagnetic-insulin

Ultrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsules